BENCHSCI
Reimagining Disease Biology Research
About us
AI-powered Drug Discovery
Our patented machine learning technology reads and understands experiments like a PhD scientist, drawing on data from over 15 million published experiments.
Global Employee Base
We have 400+ employees with diverse backgrounds and experiences. We’re remote-first, but not remote only with offices in Toronto, ON and Cambridge, UK.
Visionary Leadership
Tom Leung, David Q. Chen, Elvis Wianda, and Liran Belenzon founded BenchSci in 2015 with a shared vision to change the face of medicine and AI.
Engaged Investors
We are backed by top-tier investors including Inovia Capital, TCV, F-Prime, Gradient Ventures (Google’s AI fund), and Golden Ventures.
Explore our History
Enabling Better, Faster, Life-saving R&D
Revolutionizing Pharmaceutical Drug Discovery
We’re focused on a world where cures are discovered and brought to patients exponentially faster.
Unleashing Advanced Biomedical AI
We’re helping pharmaceutical organizations transform their R&D portfolio with patented machine learning technology.
Creating an Inclusive Culture
See how we’re embracing diverse perspectives and experiences to create a workplace where everyone belongs.